optima-logo.png
Opthea To Present at Upcoming Investor Conferences
11 mai 2022 08h00 HE | Opthea Limited
MELBOURNE, Australia, May 11, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive...
optima-logo.png
Opthea Presentation at The Retina World Congress 2022
10 mai 2022 08h20 HE | Opthea Limited
MELBOURNE, Australia, May 10, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and...